日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Induction of Nephron-Ductal Dual Lineages via Early Retinoic Acid Signaling Establishes a Platform for Fully Patterned Kidney Organoids

通过早期视黄酸信号诱导肾单位-肾导管双谱系分化,为构建完全模式化的肾脏类器官奠定了基础。

Lim, Jung Hwa; Kim, Seeun; Lee, Dong Hyun; Kim, Dae Hun; Lee, Hye Bin; Son, Ye Seul; Son, Mi-Young; Oh, Soo Jin; Lee, Ji-Yoon; Lee, Mi-Ok; Cho, Hyun Soo; Kim, Dae-Soo; Jung, Cho-Rok; Kang, Hyun Mi

Treatment Outcomes of Mycobacterium avium Complex Pulmonary Disease with a 2-drug Daily Regimen Using Macrolide and Ethambutol

采用大环内酯类和乙胺丁醇双药每日方案治疗鸟分枝杆菌复合群肺部疾病的疗效

Im, Yunjoo; Choe, Junsu; Kim, Dae Hun; Kim, Su-Young; Jhun, Byung Woo

Transdifferentiation of Integrin Beta 1 High+ Skin Progenitor Cells Into Functional Hepatocytes.

整合素β1高表达皮肤祖细胞向功能性肝细胞的转分化

Lim Jung Hwa, Kim Dae Hun, Lee Junhee, Jung Cho-Rok, Kang Hyun Mi

Sputum Microbiome Based on the Etiology and Severity of Nontuberculous Mycobacterial Pulmonary Disease

基于非结核分枝杆菌肺病病因和严重程度的痰液微生物组

Choe, Junsu; Kim, Su-Young; Kim, Dae Hun; Jhun, Byung Woo

Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease

非结核分枝杆菌肺病患者治愈状态与痰液微生物群差异的关系

Kang, Noeul; Kim, Su-Young; Kim, Dae Hun; Jhun, Byung Woo

Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure

治疗失败的鸟分枝杆菌复合群肺病患者的长期临床病程

Zo, Sungmin; Choe, Junsu; Kim, Dae Hun; Kim, Su-Young; Jhun, Byung Woo

Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment

比较病情稳定的非结核分枝杆菌肺病患者和需要治疗的患者的痰液微生物组

Song, Min Jong; Kim, Dae Hun; Kim, Su-Young; Kang, Noeul; Jhun, Byung Woo

Single-cell transcriptomics by clinical course of Mycobacterium avium complex pulmonary disease

基于单细胞转录组学的鸟分枝杆菌复合群肺病临床病程研究

Kim, Su-Young; Zo, Sungmin; Kim, Dae Hun; Shin, Sung Jae; Jhun, Byung Woo

In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance

苯并咪唑类药物(SPR719)体外活性研究:针对具有或不具有克拉霉素或阿米卡星耐药性的非结核分枝杆菌临床分离株。

Kim, Dae Hun; Zo, Sungmin; Kim, Su-Young; Jhun, Byung Woo

In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates

利福霉素衍生物对非结核分枝杆菌(包括耐大环内酯类/阿米卡星的临床分离株)的体外活性

Kim, Dae Hun; Kim, Su-Young; Huh, Hee Jae; Lee, Nam Yong; Koh, Won-Jung; Jhun, Byung Woo